Clinical trials recruiting for Circulating Tumor DNA
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Atezolizumab | 1 |
| Carboplatin | 1 |
| Cisplatin | 1 |
| Gemcitabine | 1 |
| Nivolumab | 1 |
| Pemetrexed | 1 |
| Sacituzumab govitecan | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Illinois | 1 |
| Massachusetts | 1 |
| Pennsylvania | 1 |
| Tennessee | 1 |
Top cities
Self-screener
Recruiting trials
- Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
- Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial
- Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer
- Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
- Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer
- NSCLC Liquid Biopsies and Exhaled VOC
- Using ctDNA to Determine Therapies for Lung Cancer
- ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases
Related conditions
Trials recruiting for Circulating Tumor DNA often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Circulating Tumor DNA trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.